The cytotoxic effects of lipidic formulated gold porphyrin nanoparticles for the treatment of neuroblastoma

References

• LaverdiereCLiuQYasuiYLong-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor StudyJ Natl Cancer Inst20091011131114019648511
   PubMed Web of Science ®Google Scholar
• MatthayKKVillablancaJGSeegerRCTreatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s Cancer GroupN Engl J Med19993411165117310519894
   PubMed Web of Science ®Google Scholar
• RybakLPMukherjeaDJajooSCisplatin ototoxicity and protection: clinical and experimental studiesTohoku J Exp Med200921917718619851045
   PubMed Web of Science ®Google Scholar
• KimEMooreJHuangJAll angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumorJ Pediatr Surg20013628729011172417
   PubMed Web of Science ®Google Scholar
• MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer-chemotherapy – mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCSCanc Res19864663876392
   PubMed Web of Science ®Google Scholar
• MaedaHMatsumuraYTumoritropic and lymphotropic principles of macromolecular drugsCrit Rev Ther Drug Carr Sys19896193210
   PubMed Web of Science ®Google Scholar
• JunYJKimJIJunMJSohnYSSelective tumor targeting by enhanced permeability and retention effect. Synthesis and antitumor activity of polyphosphazene-platinum (II) conjugatesJ Inorg Biochem2005991593160115963570
   PubMed Web of Science ®Google Scholar
• MaedaHThe enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targetingAdv Enz Reg200141189207
   PubMedGoogle Scholar
• TanakaTShiramotoSMiyashitaMTumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME)Int J Pharm2004277396115158968
   PubMed Web of Science ®Google Scholar
• CheCMSunRYuWYGold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cellsChem Commun20031417181719
   Web of Science ®Google Scholar
• SunRWYCheCMThe anti-cancer properties of gold(III) compounds with dianionic porphyrin and tetradentate ligandsChem Rev200925316821691
   Google Scholar
• ShawICGold-based therapeutic agentsChem Rev1999992589260011749494
   PubMed Web of Science ®Google Scholar
• ToYFSunRWYChenYGold(III) porphyrin complex is more potent than cisplatin in inhibiting growth of nasopharyngeal carcinoma in vitro and in vivoInt J Cancer20091241971197919107930
   PubMed Web of Science ®Google Scholar
• BindoliARigobelloMPScutariGThioredoxin reductase: a target for gold compounds acting as potential anticancer drugsChem Rev200925316921707
   Google Scholar
• TuSSunRWYLinMCMGold(III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancerCancer20091154459446919572413
   PubMed Web of Science ®Google Scholar
• WangYHeQYSunRWYGold(III) porphyrin 1a induced apoptosis by mitochondrial death pathways related to reactive oxygen speciesCancer Res200565115531156416357165
   PubMed Web of Science ®Google Scholar
• KoziaraJMOhJJAkersWSBlood compatibility of cetyl alcohol/polysorbate-based nanoparticlesPharm Res2005221821182816132346
   PubMed Web of Science ®Google Scholar
• AkiyamaYMoriTKatayamaYNiidomeTThe effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing miceJ Cont Rel20091398184
   PubMed Web of Science ®Google Scholar
• HsuCHCuiZMumperRJJayMPreparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursorsAAPS Pharm Sci Tech20034E32
   PubMedGoogle Scholar
• SeymourLWDuncanRStrohalmJEffect of molecular-weight (mbarw) of N-(2 hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to ratsJ Biomed Mat Res19872113411358
   PubMed Web of Science ®Google Scholar
• NagyJAHerzbergKTMasseEMExchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected miceCancer Res198949544854582475250
   PubMed Web of Science ®Google Scholar
• YuanFDellianMFukumuraDVascular permeability in a human tumor xenograft: molecular size dependence and cutoff sizeCancer Res199555375237567641188
   PubMed Web of Science ®Google Scholar
• LiWXieYSunRWYInhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibitionBr J Cancer200910134234919550420
   PubMed Web of Science ®Google Scholar
• WuJLuYLeeAReversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamilJ Pharm Pharm Sci20071035035717727798
   PubMed Web of Science ®Google Scholar
• GrunzeMHaestCWDeutickeBLateral segregation of membrane lipids and formation of stable rod-shaped membrane projections in erythrocytes treated with long-chain alcoholsBiochem Biophys Acta19826932372457150591
   PubMed Web of Science ®Google Scholar
• SchmidtMLKuzmanoffKLLing-IndeckLBetulinic acid induces apoptosis in human neuroblastoma cell linesEur J Cancer199733200720109516843
   PubMed Web of Science ®Google Scholar
• AufGChenLFornèsPCpG-oligodeoxynucleotide rejection of a neuroblastoma in A/J mice does not induce a paraneoplastic diseaseNeurosci Let200232718919212113909
   PubMed Web of Science ®Google Scholar
• KatsanisEBlazarBRBauseroMARetroperitoneal inoculation of murine neuroblastoma results in a reliable model for evaluation of the antitumor immune-responseJ Ped Surg199429538542
   PubMed Web of Science ®Google Scholar
• LiWXieYSunRWYInhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibitionBrit J Canc2009101342349
   Web of Science ®Google Scholar
• BartlettDWSuHHildebrandtIJImpact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imagingProc Nat Acad Sci U S A20071041554915554
   PubMed Web of Science ®Google Scholar